SELLAS Life Sciences Group, Inc. announced a private placement of 13,029,316 shares of common stock warrants at an exercise price of $1.41 per share on March 15, 2024. Each common warrant will be exercisable immediately on the issuance date and will expire five years and six months from the issuance date. The common warrants and the shares of our common stock issuable upon the exercise of the common warrants are not being registered under the Securities Act of 1933, as amended, were not offered pursuant to the Registration Statement and were offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act, and Rule 506(b) promulgated thereunder.

The offerings are expected to close on or about March 19, 2024, subject to customary closing conditions.